Association of Genetic Variants in Complement Factor H and Factor H-Related Genes with Systemic Lupus Erythematosus Susceptibility
Jian Zhao(Hebei Medical University), Susan A. Boackle(University of Colorado Denver), Robert P. Kimberly(Regeneron (United States)), Ji Ah Park(Seoul National University), Rosalind Ramsey‐Goldman(Northwestern University), Mary E. Comeau(North Carolina Division of Public Health), Kenneth M. Kaufman(Cincinnati Children's Hospital Medical Center), So‐Young Bang(Kyungpook National University), R. Hal Scofield(Oklahoma Medical Research Foundation), Huijuan Cui(Shanghai Jiao Tong University), Soo‐Kyung Cho(King's College London), Jennifer A. Kelly(Oklahoma Medical Research Foundation), Carl D. Langefeld(Wake Forest University), Sang‐Cheol Bae(Unknown), Joel M. Guthridge(Oklahoma Medical Research Foundation), Timothy J. Vyse(Guy's Hospital), Xiaoxia Qian(Shanghai Jiao Tong University), Deh‐Ming Chang(University of Basel), Juan‐Manuel Anaya(University of the Coast), Joan T. Merrill(Oklahoma Medical Research Foundation), Marta E. Alarcón‐Riquelme(Karolinska Institutet), Yeong Wook Song(AbbVie (United States)), Patrick M. Gaffney(Oklahoma Medical Research Foundation), Melanie Khosravi(University of California, Los Angeles), Bernardo A. Pons‐Estel(Hospital Provincial de Rosario), Gary S. Gilkeson(Medical University of South Carolina), John D. Reveille(The University of Texas Health Science Center at Houston), Timothy B. Niewold(Hospital for Special Surgery), Hui Wu(Zhejiang Lab), Lindsey A. Criswell(National Human Genome Research Institute), Diane L. Kamen(Medical University of South Carolina), Barry I. Freedman(Wake Forest University), Judith A. James(Oklahoma Medical Research Foundation), Eun Young Lee(Asan Medical Center), Elizabeth E. Brown(University of Alabama at Birmingham Hospital), Jeffrey C. Edberg(University of Alabama at Birmingham Hospital), Luis M. Vilá(University of Puerto Rico, Medical Sciences Campus), Michelle Petri(Johns Hopkins University), Adrienne H. Williams(Wake Forest University), Adam Adler(Oklahoma Medical Research Foundation), Miranda C. Marion(North Carolina Division of Public Health), Chaim O. Jacob(University of Southern California), Graciela S. Alarcón(University of Alabama at Birmingham Hospital), Anne M. Stevens(Janssen (United States)), Kathy L. Moser(Oklahoma Medical Research Foundation), Julie T. Ziegler(Wake Forest University), John B. Harley(United States Department of Veterans Affairs), Stuart B. Glenn(Oklahoma Medical Research Foundation)
Cited by 231
Related Papers
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
|New England Journal of Medicine|2005|1.1k
<i>STAT4</i> and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus
|New England Journal of Medicine|2007|1.1k